World's Best Scientists 2026 revealed!
Claude Leclerc

Claude Leclerc

D-Index & Metrics

Immunology

D-Index
84
Citations
21603
World Ranking
1404
National Ranking
54

Medicine

D-Index
84
Citations
21600
World Ranking
15277
National Ranking
494

Claude Leclerc publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Claude Leclerc sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 325 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Claude Leclerc D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Claude Leclerc sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Claude Leclerc is affiliated with Inserm in France, focusing primarily on research within Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields, including Immunology, Molecular Biology, Infectious Diseases, Epidemiology, and Radiology, Nuclear Medicine and Imaging.

The scientist's research concentrates on key topics such as Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, vaccines and immunoinformatics approaches, Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Cytomegalovirus and herpesvirus research, and Cancer Immunotherapy and Biomarkers.

Claude Leclerc has published scholarly work in various scientific journals. Notable recent papers include:

  • The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients, 2020, Cancer Immunology Immunotherapy
  • Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacteriu m tuberculosis Infection, 2020, Clinical Infectious Diseases
  • IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8 + T-cell responses, 2020, OncoImmunology
  • TLR9 activation is required for cytotoxic response elicited by baculovirus capsid display, 2022, Immunology
  • The EFIS vaccination task force expert report, 2021, European Journal of Immunology

Frequent publication venues where Claude Leclerc's work appears include:

  • Cancer Immunology Immunotherapy
  • Clinical Infectious Diseases
  • OncoImmunology
  • Immunology
  • European Journal of Immunology

Collaborations have been made with other researchers, with repeated coauthorships observed with:

  • Pierre Rosenbaum
  • Darragh Duffy
  • Matthew L. Albert
  • Cécile Artaud
  • Sylvie Bay

Best Publications

  • Neonatal adaptive immunity comes of age

    Becky Adkins;Claude Leclerc;Stuart Marshall-Clarke

  • Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.

    Alexander S. Pym;Alexander S. Pym;Priscille Brodin;Laleh Majlessi;Roland Brosch

  • The Adenylate Cyclase Toxin of Bordetella pertussis Binds to Target Cells via the αMβ2 Integrin (Cd11b/Cd18)

    Pierre Guermonprez;Nadia Khelef;Eric Blouin;Philippe Rieu

  • Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.

    M P Schutze;C Leclerc;M Jolivet;F Audibert

  • Dissection of ESAT-6 System 1 of Mycobacterium tuberculosis and Impact on Immunogenicity and Virulence

    Priscille Brodin;Laleh Majlessi;Laurent Marsollier;Marien I. de Jonge

  • Coactivation of Syk Kinase and MyD88 Adaptor Protein Pathways by Bacteria Promotes Regulatory Properties of Neutrophils

    Xiaoming Zhang;Laleh Majlessi;Laleh Majlessi;Edith Deriaud;Edith Deriaud;Claude Leclerc;Claude Leclerc

  • Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants

    Ron Dagan;Juhani Eskola;Claude Leclerc;Odile Leroy

  • Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis

    Philip Supply;Michael Marceau;Sophie Mangenot;David Roche;David Roche

  • Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP.

    Wafa Frigui;Daria Bottai;Daria Bottai;Laleh Majlessi;Marc Monot

  • Dendritic Cells Are Host Cells for Mycobacteria In Vivo That Trigger Innate and Acquired Immunity

    Xinan Jiao;Richard Lo-Man;Pierre Guermonprez;Laurence Fiette

  • Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells

    C. Sedlik;M.-F. Saron;J. Sarraseca;I. Casal

  • Upon TLR9 Signaling, CD5+ B Cells Control the IL-12-Dependent Th1-Priming Capacity of Neonatal DCs

    Cheng-Ming Sun;Edith Deriaud;Claude Leclerc;Richard Lo-Man

  • Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli.

    Darragh Duffy;Darragh Duffy;Vincent Rouilly;Valentina Libri;Milena Hasan

  • Molecular detection and in vivo analysis of the specific T cell response to a protein antigen.

    Madeleine Cochet;Christophe Pannetier;Armelle Regnault;Sylvie Darche

  • Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation.

    Daria Bottai;Mariagrazia Di Luca;Laleh Majlessi;Laleh Majlessi;Wafa Frigui

  • Functional Analysis of Early Secreted Antigenic Target-6, the Dominant T-cell Antigen of Mycobacterium tuberculosis, Reveals Key Residues Involved in Secretion, Complex Formation, Virulence, and Immunogenicity

    Priscille Brodin;Marien I. de Jonge;Laleh Majlessi;Claude Leclerc

  • Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains

    M. R. R. Lagranderie;A.-M. Balazuc;E. Deriaud;C. D. Leclerc

  • Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation

    Juliette Mouriès;Juliette Mouriès;Gabriel Moron;Gabriel Moron;Géraldine Schlecht;Géraldine Schlecht;Nicolas Escriou

  • In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help.

    C Fayolle;E Deriaud;C Leclerc

  • Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cells

    Xiaoming Zhang;Xiaoming Zhang;Edith Deriaud;Xinan Jiao;Deborah Braun

  • A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates

    Richard Lo-Man;Sophie Vichier-Guerre;Ronald Perraut;Edith Dériaud

Frequent Co-Authors

Maurice Hofnung
Maurice Hofnung Institut Pasteur
Peter Sebo
Peter Sebo Czech Academy of Sciences
Daniel Ladant
Daniel Ladant Institut Pasteur
Louis Chedid
Louis Chedid University of South Florida
Roland Brosch
Roland Brosch Institut Pasteur
Stewart T. Cole
Stewart T. Cole Institut Pasteur
Priscille Brodin
Priscille Brodin University of Lille
Agnes Ullmann
Agnes Ullmann Institut Pasteur
Sandra Hervas-Stubbs
Sandra Hervas-Stubbs University of Navarra
Alain Charbit
Alain Charbit Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare disciplines, highlighting the importance of flexible educational pathways. For those new to nursing, exploring online adn programs for non nurses can be an excellent way to enter the field while gaining essential clinical skills.

For individuals aiming to fast-track their nursing credentials, easiest absn programs to get into offer streamlined options that build on previous academic experience. These programs can help students pivot toward specialized practice areas, including immunology-related roles.

Additionally, many aspiring healthcare professionals consider lpn schools easy to get into to obtain foundational patient care skills quickly. These programs provide a practical entry into nursing while supporting career growth into advanced immunology-focused roles.

For those seeking advanced practice roles, easiest nurse practitioner program options offer accessible degrees that enable specialization, including immunology. These pathways are pivotal for nurses wanting to influence patient outcomes in immune-related health conditions.

Best Scientists Citing Claude Leclerc

Trending Scientists

Recently Published Articles